Axios @axios
The Food and Drug Administration on Tuesday approved a gene therapy for hemophilia. With a list price of $3.5 million, Hemgenix from CSL Behring LLC will become the most expensive therapy in the world. https://t.co/b9gC4CmKBl — PolitiTweet.org